Experimentally, navitoclax kills cells inside a BAX/BAK-dependent way and ends in regression of lymphoid tumors in xenograft products. In animal scientific tests, navitoclax was found to become a senolytic agent, inducing apoptosis in senescent, although not non-senescent cells.[four] Oral administration of ABT263 to either sublethally irradiated or Usually aged mice https://cdk9-in-1057923.jiliblog.com/83619817/an-unbiased-view-of-lp-935509